| Health / Medical Topics |
Tropomyosin Receptor Kinase Inhibitor AZD7451
A tropomyosin receptor kinase (TRK) inhibitor with potential antineoplastic activity. AZD7451 binds to TRK, thereby preventing the neurotrophin-TRK interaction and subsequent TRK activation. This may eventually result in an inhibition of tumor cell proliferation in TRK-expressing tumor cells. TRK, a receptor tyrosine kinase activated by neurotrophins, is mutated in a variety of cancer cell types and plays an important role in tumor cell growth, invasion and survival. (NCI Thesaurus)
YOU MAY ALSO LIKE
Tropomyosin alpha-4 chain (248 aa, ~29 kDa) is encoded by the human TPM4 gene. This protein is involved in both muscle contraction…
Tropomyosin alpha-3 chain (284 aa, ~33 kDa) is encoded by the human TPM3 gene. This protein plays a role in the modulation…
Tropomyosin alpha-1 chain (284 aa, ~33 kDa) is encoded by the human TPM1 gene. This protein plays a role in muscle…
Tropomodulin-3 (352 aa, ~40 kDa) is encoded by the human TMOD3 gene. This protein is involved in the negative regulation of both…
A drug used to prevent nausea and vomiting caused by cancer treatment. It is also used to prevent nausea and vomiting after…
A synthetic muscarinic antagonist with actions similar to atropine and with an anticholinergic property. Upon ocular administration, tropicamide binds to and blocks…
